151 related articles for article (PubMed ID: 9748012)
21. Nerve growth factor in diabetic neuropathy.
Anand P
Lancet; 1998 Nov; 352(9140):1629-30. PubMed ID: 9843133
[No Abstract] [Full Text] [Related]
22. Nerve growth factor (NGF) may hold promise in treatment of peripheral neuropathy.
AIDS Patient Care STDS; 1997 Jun; 11(3):197. PubMed ID: 11361801
[No Abstract] [Full Text] [Related]
23. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.
Malik RA; Williamson S; Abbott C; Carrington AL; Iqbal J; Schady W; Boulton AJ
Lancet; 1998 Dec 19-26; 352(9145):1978-81. PubMed ID: 9872248
[TBL] [Abstract][Full Text] [Related]
24. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.
Kochar DK; Rawat N; Agrawal RP; Vyas A; Beniwal R; Kochar SK; Garg P
QJM; 2004 Jan; 97(1):33-8. PubMed ID: 14702509
[TBL] [Abstract][Full Text] [Related]
25. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
McArthur JC; Yiannoutsos C; Simpson DM; Adornato BT; Singer EJ; Hollander H; Marra C; Rubin M; Cohen BA; Tucker T; Navia BA; Schifitto G; Katzenstein D; Rask C; Zaborski L; Smith ME; Shriver S; Millar L; Clifford DB; Karalnik IJ
Neurology; 2000 Mar; 54(5):1080-8. PubMed ID: 10720278
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophic factors and diabetic peripheral neuropathy.
Apfel SC
Eur Neurol; 1999; 41 Suppl 1():27-34. PubMed ID: 10023126
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial.
Ropper AH; Gorson KC; Gooch CL; Weinberg DH; Pieczek A; Ware JH; Kershen J; Rogers A; Simovic D; Schratzberger P; Kirchmair R; Losordo D
Ann Neurol; 2009 Apr; 65(4):386-93. PubMed ID: 19399887
[TBL] [Abstract][Full Text] [Related]
28. The role of endogenous nerve growth factor in human diabetic neuropathy.
Anand P; Terenghi G; Warner G; Kopelman P; Williams-Chestnut RE; Sinicropi DV
Nat Med; 1996 Jun; 2(6):703-7. PubMed ID: 8640566
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.
Schifitto G; Yiannoutsos C; Simpson DM; Adornato BT; Singer EJ; Hollander H; Marra CM; Rubin M; Cohen BA; Tucker T; Koralnik IJ; Katzenstein D; Haidich B; Smith ME; Shriver S; Millar L; Clifford DB; McArthur JC;
Neurology; 2001 Oct; 57(7):1313-6. PubMed ID: 11591856
[TBL] [Abstract][Full Text] [Related]
30. Neurotrophic factors in the therapy of diabetic neuropathy.
Apfel SC
Am J Med; 1999 Aug; 107(2B):34S-42S. PubMed ID: 10484043
[TBL] [Abstract][Full Text] [Related]
31. Neurotrophic factors in the treatment of peripheral neuropathy.
Apfel SC; Kessler JA
Ciba Found Symp; 1996; 196():98-108; discussion 108-12. PubMed ID: 8866130
[TBL] [Abstract][Full Text] [Related]
32. Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.
Bertelsmann FW; Heimans JJ; Van Rooy JC; Dankmeijer HF; Visser SL; Van der Veen EA
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1337-41. PubMed ID: 3681313
[TBL] [Abstract][Full Text] [Related]
33. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
[TBL] [Abstract][Full Text] [Related]
34. Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides.
Bassi S; Albizzati MG; Calloni E; Frattola L
Muscle Nerve; 1982; 5(5):351-6. PubMed ID: 6289096
[TBL] [Abstract][Full Text] [Related]
35. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment].
Maeda K; Yasuda H
Nihon Rinsho; 1999 Mar; 57(3):578-83. PubMed ID: 10199137
[TBL] [Abstract][Full Text] [Related]
36. Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy.
Windebank AJ; Sorenson EJ; Civil R; O'Brien PC
J Peripher Nerv Syst; 2004 Sep; 9(3):183-9. PubMed ID: 15363067
[TBL] [Abstract][Full Text] [Related]
37. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
Soin A; Bock G; Giordano A; Patel C; Drachman D
Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
[TBL] [Abstract][Full Text] [Related]
38. The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes.
Jin YP; Su XF; Li HQ; Wu JD; Ding B; Sun R; Shan T; Ye L; Ma JH
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):618-621. PubMed ID: 27701714
[No Abstract] [Full Text] [Related]
39. Expression of neurotrophic factors in diabetic muscle--relation to neuropathy and muscle strength.
Andreassen CS; Jakobsen J; Flyvbjerg A; Andersen H
Brain; 2009 Oct; 132(Pt 10):2724-33. PubMed ID: 19696031
[TBL] [Abstract][Full Text] [Related]
40. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
